Log in to save to my catalogue

Stereotactic reirradiation with temozolomide in patients with recurrent aggressive pituitary tumors...

Stereotactic reirradiation with temozolomide in patients with recurrent aggressive pituitary tumors...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2421108644

Stereotactic reirradiation with temozolomide in patients with recurrent aggressive pituitary tumors and pituitary carcinomas

About this item

Full title

Stereotactic reirradiation with temozolomide in patients with recurrent aggressive pituitary tumors and pituitary carcinomas

Publisher

New York: Springer US

Journal title

Journal of neuro-oncology, 2020-08, Vol.149 (1), p.123-130

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Objectives
To evaluate the efficacy of a second course of fractionated stereotactic radiotherapy (re-SRT) and temozolomide (TMZ) as salvage treatment option in patients with aggressive pituitary tumors (APTs) and pituitary carcinomas (PCs).
Patients and Methods
Twenty-one patients with recurrent or progressive APTs (n = 17) and PCs (n = 4)...

Alternative Titles

Full title

Stereotactic reirradiation with temozolomide in patients with recurrent aggressive pituitary tumors and pituitary carcinomas

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2421108644

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2421108644

Other Identifiers

ISSN

0167-594X

E-ISSN

1573-7373

DOI

10.1007/s11060-020-03579-5

How to access this item